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Edited by Vladimir SkulachevAbstract Glial cells missing a (GCMa) belongs to a new tran-
scription factor family. Syncytin was shown to be a target gene
of GCMa. Here, we demonstrate that the protein kinase A
(PKA) pathway acts upstream of GCMa. After transient trans-
fection of BeWo cells with PKA, GCMa transcriptional activity
and both GCMa and syncytin transcripts were upregulated. This
increase was accompanied by further cellular diﬀerentiation.
Using normoxic or hypoxic conditions to mimic pathophysiolog-
ical settings known to diminish trophoblast diﬀerentiation, we
found that gene repressive eﬀects of oxygen deﬁciency were com-
pensated by the induction of the PKA pathway. We propose that
GCMa-driven syncytin expression is the key mechanism for syn-
cytiotrophoblast formation.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Glial cells missing a (GCMa) is a mammalian member of a
recently identiﬁed transcription factor family, characterized
by a zinc-coordinating DNA binding domain at the amino-
terminus. This DNA binding domain is composed of two sub-
domains each largely consisting of b-sheets. The interaction of
GCM family members with their cognate octameric GCM
binding motif 5 0-ATGCGGGT-3 0 is mediated by contacts be-
tween amino acid residues of the b-sheets and the major
groove of the DNA [1]. All members of the GCM family so
far identiﬁed are key regulators of diﬀerentiation processes
[2]. In mammals, GCMa gene expression is restricted to pla-Abbreviations: cAMP, either dibutyryl-cAMP or 8-Br-cAMP; Cx43,
connexin-43; DAPI, 4,6-diamidine-2 0-phenylindole dihydrochloride;
b-HCG, b-human chorionic gonadotropin; PKA, protein kinase A;
FAM, 6-carboxy-ﬂuorescein; FACS, ﬂuorescence-activated cell sort-
ing; FCS, fetal calf serum; GCMa, glial cells missing a; LTR, long
terminal repeat; TAMRA, 6-carboxy-tetramethyl-rhodamine; GFP,
green ﬂuorescent protein; RFP, red ﬂuorescent protein
*Corresponding author. Fax: +49 9131 852 2484.
E-mail address: sh@biochem.uni-erlangen.de (S. Hashemolhosseini).
1 Both authors contributed equally to this work.
0014-5793/$30.00  2005 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2005.06.029centa, kidney and thymus [3–5]. Ablation of GCMa in mice re-
sulted in midembryonal death due to failure to develop a
functional placental syncytiotrophoblast layer [6,7]. During
embryonic development, the syncytiotrophoblast provides
the embryo with nutrients and oxygen. The human syncytio-
trophoblast originates from adjacent cytotrophoblast cells.
The basic mechanisms of syncytiotrophoblast formation and
the regulatory inﬂuence of oxygen still have to be elucidated.
A known key molecule for placental syncytium formation is
syncytin, a fusogenic glycoprotein originally derived from an
endogenous retrovirus [8,9]. Syncytin was reported as one of
the ﬁrst placental target genes stimulated by GCMa [10]. Its
production in the placenta is followed by placental diﬀerentia-
tion processes, such as the formation of intercellular gap junc-
tions, cell syncytialization, and an increase of b-human
chorionic gonadotropin (b-HCG) secretion [11]. Accordingly,
the expression pattern of the gap junction forming connexins,
such as connexin-43 (Cx43) is related speciﬁcally to the stage of
placental diﬀerentiation [12,13].
Pre-eclampsia, clinically deﬁned by hypertension and pro-
teinuria [14], is still one of the main causes of maternal and
perinatal morbidity. Although the pathogenesis is unex-
plained, an abnormal placental development is an underlying
cause along with alterations in local oxygen availability
[15,16]. It was shown that syncytin is downregulated under
hypoxic conditions at the transcriptional level [17,18]. Further-
more, a diminished syncytin gene expression and deregulated
protein distribution are found in placentas of pre-eclamptic
women [19,20]. It seems likely that in pre-eclampsia placental
oxygen deﬁciency is responsible for the reduction of syncytin
transcription. Additionally, decreased placental GCMa
mRNA and protein levels have been found in placentas of
pre-eclamptic women [21].
For some time, molecular mechanisms of the embryonic
lethality of GCMa-deﬁcient mice were considered syncytin
independent, since no syncytin was identiﬁed in rodents. But
recently, two murine syncytin genes of retroviral origin have
been identiﬁed, giving rise to the assumption that GCMa-
deﬁcient mice die due to missing syncytin gene expression in
murine syncytiotrophoblast progenitor cells [22].
Here, we elucidate upstream GCMa/syncytin signaling
mechanisms by demonstrating that the dibutyryl-cAMP or
8-Br-cAMP (cAMP)-driven protein kinase A (PKA) signaling
pathway stimulates syncytin and GCMa expression in both
primary trophoblasts and BeWo choriocarcinoma cells. Theation of European Biochemical Societies.
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trancriptional activity in BeWo choriocarcinoma cells. Subse-
quently, we found that hypoxia-mediated downregulation of
GCMa and syncytin expression is compensated by concurrent
induction of the PKA signaling pathway.2. Materials and methods
2.1. Cell culture
BeWo cells were purchased from the Deutsche Sammlung von
Mikroorganismen und Zellkulturen GmbH (Braunschweig, Germany)
and cultivated as described [17]. After approval by the local ethics
committee, term trophoblast cells were isolated using a trypsin-DNA-
seI percoll gradient centrifugation method [23,24] and cultured in
DMEM with 10% fetal calf serum (FCS). Cells were grown at 37 C
under normoxia with 95% air, 5% CO2, or low oxygen conditions with
either 3% or 1% O2 (Forma Scientiﬁc). Oxygen tension was 142 mmHg
for the normoxic setting compared to 21 and 7 mmHg in the hypoxic
setting. For further experimental studies, cells were seeded into tripli-
cate wells of 6-well-plates (Life Technologies) at a density of 1 · 105
cells/cm2 and, after adherence, maintained under normoxic or hypoxic
conditions for 24–48 h in the presence or absence of diﬀerent stimuli
and chemicals as indicated. Stimulation of the cAMP pathways was
performed using 100 lM forskolin or 150 lM cAMP. For the inhibi-
tion of de novo protein synthesis 30 min before cAMP treatment 100
lg of cycloheximide (Sigma Chemicals) per ml medium was added.
All experiments were repeated at least three times.
2.2. Cell vitality and detection of apoptosis
Loss of viability was ruled out by using trypan blue staining. Apop-
tosis was detected by ﬂuorescence-activated cell sorting (FACS) with
Annexin-V and propidium iodine double staining (Alexis Biochemi-
cals), using the FACS Calibur ﬂow cytometer and CellQuest software
(Becton–Dickinson) as published earlier [25].
2.3. Fluorescence immunocytochemistry
Conﬁguration of gap junctions was shown by immunolabeling for
Cx43 and cell fusion by a reduction of the amount of desmoplakin.
Cells were ﬁxed with 4% paraformaldehyde and incubated with a rab-
bit polyclonal antibody reactive against Cx43 (dilution 1:200), fol-
lowed by an Alexa 488-conjugated goat anti-rabbit IgG (dilution
1:250) treatment [26]. For desmoplakin analysis, cells were ﬁxed with
ice-cold methanol. A monoclonal antibody against desmoplakin was
used (dilution 1:200) followed by an Alexa 488-coupled goat-anti-
mouse IgG (dilution 1:250) treatment. All antibodies were obtained
either from Chemicon or MoBiTec. Visual evaluation was performed
using a BX60 microscope (Olympus) and the software and camera sys-
tem F-View II-Kamera (Soft Imaging System).
2.4. Molecular analysis and real-time PCR
Reverse transcription (RT) of 1.5 lg to 1 mg total RNA was per-
formed after RNA extraction with the phenol/guanidine isothiocyanate
method followed by DNAse-I digestion [17]. GCMa expression studies
were carried out using the LightCycler-FastStart DNA Master SYBR
Green kit and the LightCycler Thermal Cycle system (Roche Applied
Science) [27]. Gene expression of syncytin was quantiﬁed using real-time
PCR (Applied Biosystems). All values were normalized to b-actin
mRNA amounts. Increase of GCMa and syncytin levels in response to
constitutive PKAexpressionwas determined usingRNAextracted from
BeWo cells transiently transfected by a CMV-driven plasmid expressing
the catalytical subunit of PKA. Co-transfection of a green ﬂuorescent
protein (GFP) plasmid (Clontech) was always used for calculation of
the transfection eﬃciency. For TaqMan PCR, ﬂuorogenic probes have
been used, containing a reporter dye (6-carboxy-ﬂuorescein, FAM) at
the 5 0-end and a quenching dye (6-carboxy-tetramethyl-rhodamine,
TAMRA) at the 3 0-end [17]. The following RT-PCR primers have been
used: Syncytin 5 0CGTACCCATACTCGCCTGGTA3 0, 5 0GGTTTT-
GGGCCGAGACCT3 0, 5 0(FAM)-CCTATTTAATACCACCCTCAC-
TGGGCTCCA-(TAMRA)3 0; GCMa 5 0GAACCTGACGACTCTG-
ATTC30, 5 0TGTCACAGATGGCAGGTCTC3 0; b-actin 5 0GCGAGA-
AGATGACCCAGGATC30, 5 0CCAGTGGTACGGCCAGAGG30 or5 0(FAM)-CCAGCCATGTACGTTGCTATCCAGGC-(TAMRA)3 0,
5 0AGCACGGCATCGTCACCAAC3 0, 5 0GCCGTGGTGGTGAAG
CT GTA3 0. The CMV expression plasmids encoding the DNA-binding
domain of GCMa (GCMa-220) have been described [27]. As marker for
GCMa-220 co-transfected cells a CMVexpression plasmid encoding red
ﬂuorescent protein (RFP) (Clontech) was used. Statistical analysis was
performed using unpaired two-tailed t-test or Mann–Whitney test.
2.5. Transfection, luciferase assays, extract preparation and Western
blot
A luciferase reporter plasmid containing six tandemly arranged
modules of GCM-binding sites and a TATA box was transiently trans-
fected into BeWo cells to measure the activity of endogenous GCMa
protein [28]. For luciferase assays 60-mm dishes were used and trans-
fected with 2 lg of total DNA. Transfected cells were either incubated
with 100 lM forskolin or 150 lM cAMP for up to 48 h. At 48 h post-
transfection, cells were harvested for luciferase assays or extract prep-
aration as described [27]. Luciferase activities were compared with
mock-treated cells. Experiments were performed in duplicate three
independent times. A polyclonal rabbit serum against the carboxyl-ter-
minal half of GCMa served as primary antibody (1:3000 dilution),
horseradish-peroxidase-coupled-protein A as secondary detection re-
agent in Western blots using the ECL detection system (Amersham
Biosciences).2.6. Hormone measurements
Active free b-HCG in culture media was measured using an enzyme-
linked immunosorbent assay kit (DRG International) with a sensitivity
of 1.0 mIU/mL and inter- and intra-assay variation coeﬃcients of less
than 10%.3. Results
3.1. GCMa and syncytin gene expression is stimulated by cAMP
and preserved during concomitant hypoxia
It is known that forskolin stimulates syncytin gene expres-
sion and cell fusion in BeWo choriocarcinoma cells, but so
far details of this signaling pathway have not been reported.
Because previous results implicated a potential involvement
of PKA, we ﬁrst studied by real-time PCR whether tropho-
blast cells might upregulate gene expression levels of GCMa
and syncytin as a response to PKA stimulating agents. For this
purpose, we applied in BeWo cells and in primary term human
trophoblasts either forskolin or cAMP, which directly and
exclusively stimulate the PKA signaling pathway. In addition,
we studied the inﬂuence of diﬀerent oxygen levels, because a
decrease of oxygen concentration in the placenta results in dis-
turbed placentogenesis such as pre-eclampsia. Considering the
low level of oxygen in the placental tissue we incubated the
trophoblastic cells either with 3% or with 1% O2.
Stimulation of BeWo cells with forskolin or cAMP for 24–
48 h enhanced syncytin expression by 3–4-fold (Fig. 1A). Pri-
mary human trophoblasts exhibited an even higher response
after incubation with either of the two compounds by up to
8-fold compared to un-stimulated control cells (Fig. 1B). Sub-
sequently, we studied the inﬂuence of low oxygen levels on
GCMa and syncytin gene expression in trophoblasts following
treatment with PKA stimulating agents. Previous reports have
demonstrated that syncytin transcripts are downregulated in
trophoblastic cells incubated with lower oxygen doses. As
expected, the amounts of syncytin transcripts decreased in hyp-
oxic trophoblasts compared to trophoblastic cells incubated
under normoxic conditions (Fig. 1A, P = 0.042; Fig. 1B,
P = 0.041). But, syncytin transcript levels were almost
unaﬀected when hypoxia-incubated trophoblastic cells were
Fig. 1. Increased expression of GCMa and syncytin in BeWo cells and primary human trophoblasts following forskolin or cAMP stimulation.
Syncytin (A,B) or GCMa (C,D) mRNA levels in trophoblastic cells in the presence or absence of 100 lM forskolin or 150 lM cAMP for 48 h as
indicated. Cells were grown under either normoxic conditions or oxygen deﬁciency (BeWo 3% O2, trophoblast 1% O2). Increased GCMa activity in
both forskolin or cAMP treated BeWo cells is demonstrated by transient transfection of a GCM binding sites containing luciferase reporter plasmid
(E). All gene expression levels are normalized to b-actin. P-values <0.05 to <0.001.
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Therefore, the hypoxia-related decline of syncytin expression
in BeWo cells and trophoblasts was, to a great extent, prevent-
able by the co-stimulation with cAMP agonists (Fig. 1A,B).
Subsequently, we studied the eﬀect of cAMP agonists on the
transcription of GCMa. A previous report demonstrated
syncytin as target of GCMa, suggesting that PKA dependent
upregulation of GCMa might be responsible for the increase
of syncytin transcripts via two GCMa-binding sites in the
up-stream region of the 5 0-LTR of the syncytin gene [10]. As
observed for syncytin, the treatment with either forskolin or
cAMP for 24–48 h under normoxic conditions increased the
expression of endogenous GCMa up to 5-fold in BeWo cells
compared to un-stimulated control cells (Fig. 1C). Under hyp-
oxic conditions, GCMa transcript amounts were signiﬁcantly
downregulated in both untreated BeWo cells and primary tro-phoblasts (Fig. 1C,D; P = 0.003, P = 0.012, respectively).
When BeWo cells cultured under low oxygen levels were trea-
ted with cAMP agonists, a comparable increase in GCMa
transcript levels was observed as for BeWo cells grown under
normoxic conditions (Fig. 1C). Interestingly, cAMP agonists
counteract a loss of GCMa transcripts in primary trophoblasts
grown under hypoxia to a smaller extent compared to cells cul-
tured under normoxia (Fig. 1D). To test whether the stimula-
tion of the PKA pathway also increased endogenous GCMa
protein activity, we carried out transient transfection on BeWo
cells with a reporter built from six tandemly arranged modules
of synthetic GCMa binding sites and a TATA box 5 0 to a lucif-
erase gene. When cells were incubated post-transfection with
either forskolin or cAMP agonists for 48 h, we observed an
up to 3-fold increase in luciferase activity compared to
mock-treated controls (Fig. 1E).
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To study functional diﬀerentiation of trophoblastic cells
we measured b-HCG production and secretion in the cell
supernatant. As expected, the increase of GCMa mRNA
and protein activity along with syncytin gene transcription
in trophoblastic cells was accompanied by a time-dependent
b-HCG accumulation in the cell medium (Fig. 2A). Further-
more, with additional forskolin stimulation over 48 h, we
observed 35-fold higher concentrations for b-HCG. After
48 h of cell growth under hypoxic conditions, cAMP-stimu-
lated b-HCG concentrations in the cell culture medium were
25-fold higher than under control conditions. For hypoxic
experiments, it was of interest to control for cell viabilityFig. 2. Adenylate cyclase activator forskolin stimulates functional and
morphological diﬀerentiation under normoxia and is largely protective
under hypoxia. Treatment of BeWo cells with cAMP agonists induces
functional diﬀerentiation as depicted on increased b-HCG secretion in
the cell culture supernatant (A). Measurements were performed by
ELISA from triplicates. P-values <0.01. Immunocytochemical detec-
tion of gap junctional protein Cx43 in BeWo cells incubated under
normoxic conditions without (B) and with 100 lM forskolin (C) for
24 h and under 1% O2 in the presence (D) or absence of forskolin (E)
for the same period. Cx43 is visible as green punctuate immunoﬂu-
orescence at the cell boundaries and around nuclei. Cell nuclei were
labeled with DAPI (blue color). In forskolin stimulated cells Cx43
punctuate immunoﬂuorescence is increased. Hypoxia diminishes Cx43
immunostaining compared to normoxia. Hypoxia-related arrest of gap
junctional Cx43 immunoreactivity is, to a great extent, compensated
for by the induction of cAMP/PKA pathways.and apoptotic response. When investigating the apoptotic
rate, we found a mean apoptotic rate of 4–10% in normoxic
and 3–21% in hypoxic trophoblastic cells and a mean cell
viability of 79–93% for both BeWo cells and primary tro-
phoblasts.
We also analyzed the presence of Cx43, a major gap junc-
tional protein in trophoblast. Cx43 is localized, for example,
between cytotrophoblastic cells and the syncytiotrophoblast,
allows intracellular communication, and is associated with
the fusion process. Trophoblastic cells exhibited an intensive
punctuate Cx43 immunostaining during cell diﬀerentiation
predominantly at the cell boundary and around nuclei (la-
beled with 4,6-diamidine-2 0-phenylindole dihydrochloride,
DAPI) as early as 24 h after the onset of incubation with
cAMP agonists or forskolin compared to unstimulated con-
trol cells (Fig. 2B–E). This phenomenon is indicative for an
increase of intercellular gap junction formation. Adenylate
cyclase activator forskolin preserved Cx43 immunoﬂuores-
cence at the cell boundarys and around nuclei under hypox-
ia with 3% or 1% O2 for 24 h compared to hypoxic cells
without cAMP stimulation (Fig. 2D,E). As expected, activa-
tion of the cAMP/PKA pathway led to a diminished immu-
noﬂuorescent staining for desmosomal protein desmoplakin
and an increased number of DAPI-stained nuclei within syn-
cytia compared to standard culture conditions, whereas the
co-application of hypoxic stimuli and forskolin led to a
weaker diminution of desmoplakin immunoreactivity, in
accordance with a reduced but continuing cell fusion (data
not shown).3.3. Endogenous GCMa and syncytin expression increased in
BeWo cells transfected by a constitutively active catalytic
PKA subunit
Up to now, our data indicate that the stimulation of PKA
signaling leads to an increase of GCMa transcript levels,
which most likely is responsible for a concomitant increase
of the amount of syncytin transcript. To investigate the
involvement of the PKA pathway directly, we analyzed if
constitutively active PKA expression in trophoblastic cells
is able to increase the transcription rate of GCMa and
syncytin. We therefore transfected the catalytic subunit of
PKA into BeWo cells, and performed RNA extraction after
48 h followed by cDNA synthesis and real-time PCR to test
for a potential increase of either GCMa or syncytin tran-
script levels. Although only 10% of the BeWo cells were
transfected as evidenced by co-transfected GFP (data not
shown), we still observed a 2-fold increase of the amount
of GCMa transcripts (Fig. 3A). Next, we determined if the
increase of GCMa mRNA correlates with an increase of
GCMa protein activity. Indeed, we observed an almost
8-fold increase in luciferase activity if we co-transfected plas-
mids containing the catalytical subunit of PKA together
with a GCM-dependent luciferase reporter (Fig. 3B). At
the same time, we observed a 3-fold increase of the amount
of syncytin transcripts (Fig. 3C). Indeed, by transiently
transfecting BeWo cells with the catalytical subunit of
PKA and immunostaining them with the marker Cx43, we
observed a far stronger signal compared to BeWo cells
transfected with the empty vector (Fig. 3D,E). This demon-
strates that PKA activity is suﬃcient to increase cell diﬀeren-
tiation in trophoblastic cells.
Fig. 3. BeWo cells transfected with a plasmid encoding the catalytical PKA subunit exhibit increased expression of GCMa, syncytin, and Cx43.
BeWo cells were transiently transfected with the catalytic subunit of PKA and, following RNA extraction, gene expression of GCMa (A) and
syncytin (C) were measured by real-time RT-PCR and compared with mock transfected controls (empty vector). Increased activity of GCMa
following transient co-transfection of a GCM binding sites containing reporter plasmid was assayed measuring luciferase activity (B). P-values <0.05.
Immunocytochemical detection of gap junctional membrane protein Cx43 in BeWo cells transiently transfected with empty vector (D) or with the
catalytical subunit of PKA (E) incubated under normoxic conditions. Cell nuclei were labeled with DAPI (blue color).
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protein synthesis and stabilizes GCMa protein
We tested if de novo protein synthesis is required for the
stimulation of GCMa and syncytin expression by PKA. For
this purpose, we pretreated BeWo cells with cycloheximide
and incubated them with cAMP over diﬀerent time periods,
followed by the determination of GCMa and syncytin tran-
scripts using real-time RT-PCR. In BeWo cells not treated
with cycloheximide, the amount of GCMa mRNA increased
after treatment of cells with cAMP (Fig. 4A). Interestingly, a
signiﬁcantly higher increase of the mRNA level of GCMa
was observed after simultaneous treatment with cyclohexi-
mide for 6–8 h (Fig. 4A). This increase of GCMa transcripts
is comparable to an increase of transcript amounts of sev-
eral proteins in response to cycloheximide treatment, like
c-fos [29], presumably due to mRNA stabilization. Syncytin
transcript levels increased slightly after cAMP treatment for
up to 8 h (Fig. 4B). Surprisingly, in the presence of cyclo-
heximide we observed higher levels of syncytin transcripts
(Fig. 4B).
The half-life of GCMa protein is approximately 2.5 h under
standard cell culture conditions [30]. To analyze whether
GCMa protein is stabilized in the presence of PKA, we tran-
siently transfected GCMa alone or together with the catalytical
subunit of PKA into BeWo cells. We observed a signiﬁcantly
higher amount of GCMa protein in GCMa plus PKA co-
transfected BeWo cells than in cells only transfected with
GCMa (Fig. 4C). Since endogenous GCMa protein is not de-
tected at the short exposure time used for detection of the Wes-
tern blot in control cells or after transfection with PKA alone,
we conclude that transfected GCMa protein is stabilized in the
presence of PKA activity, thereby stimulating the transcription
of the syncytin gene in the absence of de novo GCMa protein
synthesis.3.5. A dominant-negative GCMa protein inhibits cell fusion
events in choriocarcinoma cells
Previously, it has been demonstrated that syncytin is a direct
target of GCMa, since the syncytin promoter contains two
GCM-binding motifs [10,31]. We asked if under PKA-acti-
vated conditions there is still a link between GCMa/syncytin
expression and cellular diﬀerentiation. First, we proved that
a protein fragment of GCMa, the isolated GCMa DNA-binding
domain, is able to act as a dominant-negative mutant.
Transient transfection of a GCMa DNA-binding domain
(GCMa-220) containing an expression plasmid together with
full length GCMa almost completely abolished GCMa-depen-
dent reporter gene expression (Fig. 5A). We then transiently
transfected BeWo cells with GCMa-220 together with RFP.
After incubation of these cells with cAMP for 24 h we immu-
nostained them with Cx43 as marker for cell diﬀerentiation
and gap junction formation. A considerable lower amount of
Cx43 staining indicated that RFP-labeled cells do not diﬀeren-
tiate further, most likely due to blocked GCMa and syncytin
expression (Fig. 5B,C).4. Discussion
So far, upstream pathways regulating GCMa/syncytin sig-
naling were entirely unknown. Our data illustrate that the
GCMa/syncytin signaling is upregulated by the cAMP-driven
PKA pathway. The in vivo impact of our results is supported
by the fact that PKA signaling stimulates GCMa and syncytin
expression in primary trophoblasts. Therefore, GCMa con-
trolled syncytin expression by PKA might be a key mechanism
for human syncytiotrophoblast formation.
It has been demonstrated previously that PKA regulates
transcription through phosphorylation [32,33]. Indeed, using
Fig. 4. Increase of syncytin transcript levels in BeWo cells after
inhibition of de novo protein synthesis is due to GCMa protein
stabilization. BeWo cells were incubated with cAMP alone or together
with cycloheximide (CHX) as indicated. Endogenous mRNA levels of
GCMa (A) or syncytin (B) were then measured by real-time RT-PCR,
normalized to b-actin. P-values <0.05. BeWo cells were transiently
transfected with the empty vector, GCMa, PKA, or GCMa plus PKA.
GCMa protein was detected from cell extracts by western blot (C).
Note that in the presence of PKA the amount of GCMa protein is
considerably higher.
Fig. 5. A dominant-negative GCMa protein blocks PKA-GCMa–
syncytin mediated increase of Cx43. Transient transfection of BeWo
cells with six tandemly arranged GCM-binding motifs containing
luciferase as reporter together with either GCMa alone or GCMa and
a dominant-negative GCMa fragment (A; GCMa-220). P-values
<0.05. BeWo cells were transiently co-transfected with RFP (as
marker for the identiﬁcation of transfected cells) and a dominant-
negative GCMa fragment. After stimulation with cAMP for 24 h, cells
were immunostained for Cx43 as a marker for functional cellular
diﬀerentiation. A representative example of two RFP labelled cell (B),
exhibiting less intense Cx43 immunostaining is depicted (C, circled
area).
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phorylation sites within the primary sequence of mouse GCMa
(data not shown). Thus, GCMa might be directly phosphory-
lated by PKA activity and as a consequence be stimulated in
its transcriptional activity. Another possibility would be that
phosphorylated GCMa has a longer half life thus indirectly
increasing GCMa amounts and activity. Indeed, we observed
that GCMa protein is stabilized in response to PKA activity.
In addition to activation and stabilization of GCMa through
phosphorylation by PKA it might also be possible that PKA
activates cofactors through phosphorylation such as CREM
binding protein, CBP. Previously, CBP has been shown to act
jointly with proteins such as CREM/CREB/ATF1 or NFjB
[34,35] andmight also be able to associate and therebymodulate
the DNAbinding capacity of GCMa. Furthermore, stimulation
of GCMa activity is also arranged through increased expressionof theGCMa gene, as shown in this study. Transcription factors
such as CREM or CREBmay be activated by PKA and directly
interact with the GCMa promoter. Interestingly, bindingmotifs
for CREM and CREB are localized in the GCMa promoter
(data not shown).
Concomitantly in this study, we demonstrate that hypoxia-
related downregulation of syncytin transcription in tropho-
blasts can be, to a great extent, compensated by stimulating
the cAMP-driven PKA pathway, facilitating further cellular
diﬀerentiation of syncytiotrophoblasts, as evidenced by an in-
crease of gap junction formation. Interestingly, under hypoxic
conditions the transcription of GCMa was compensated to a
lower degree compared with the transcription of syncytin by
stimulation of the PKA pathway. This may indicate that, at
I. Knerr et al. / FEBS Letters 579 (2005) 3991–3998 3997least under hypoxia, syncytin gene expression is modulated not
only by increased GCMa expression.
During syncytialization the cell-to-cell communication re-
quires Cx43-dependent formation of gap junctions for the ﬂux
of signal molecules such as cAMP and Ca2+. Previous ﬁndings
show that Cx43 can be regulated by cAMP, b-HCG, estrogens,
and possibly by syncytin in human trophoblasts and may be
directly involved in the formation of syncytiotrophoblast
[26]. Cx43 may, therefore, be a putative eﬀector molecule for
the cAMP/PKA mediated GCMa–syncytin pathway. In sup-
port of this assumption, it was demonstrated that in granulosa
cells Cx43-type gap junctions are regulated by PKA [36]. It was
reported that syncytin gene expression is downregulated under
hypoxia and that diminished syncytin transcription and dereg-
ulated protein distribution can be found in placentas from pre-
eclamptic women [19,20]. We therefore propose that an altered
syncytin activation downstream the cAMP-driven PKA-
GCMa signaling cascade is a major risk factor for diminished
trophoblast diﬀerentiation and impaired syncytiotrophoblast
formation, further increasing the risk of placental dysfunction
in the course of placental hypoxia. Elucidation of the underly-
ing mechanisms of oxygen variation has shown that hemopro-
teins and mitochondria may play a pivotal role in the detection
of local oxygen tension. Additionally, adaptive response to
oxygen deprivation is mediated through the increase of HIF-
1a protein, a mechanisms that may be aﬀected in pre-eclampsia
[37].
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